News Snapshot:
New Delhi: Moody's Analytics on Monday said India, along with China, would take lead in the COVID-19 vaccine distribution in the Asia-Pacific region. India launched its vaccination programme on January 16 after the drug regulator DCGI earlier this month approved Oxford COVID-19 vaccine Covishield , manufactured by the Serum Institute of India, and Bharat Biotech's indigenously developed Covaxin , for restricted emergency use in the country. Moody's Analytics said the Indian government plans to inoculate nearly 300 million high-priority people, including health workers, the elderly, and those with higher comorbidities by August. "This is an important development. As India is...
